Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California. more
Time Frame | TLPH | Sector | S&P500 |
---|---|---|---|
1-Week Return | -3.37% | -2.82% | 0.15% |
1-Month Return | -27.79% | -4.22% | 1.78% |
3-Month Return | -26.99% | -9.52% | 8.7% |
6-Month Return | -32.95% | -3.45% | 12.24% |
1-Year Return | -1.93% | 5.62% | 30.9% |
3-Year Return | -93.68% | 3.8% | 30.19% |
5-Year Return | -98.58% | 39.68% | 91.72% |
10-Year Return | -99.49% | 105.02% | 203.2% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 2.29M | 5.42M | 2.82M | 1.77M | 651.00K | [{"date":"2019-12-31","value":42.26,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":52.03,"profit":true},{"date":"2022-12-31","value":32.7,"profit":true},{"date":"2023-12-31","value":12.02,"profit":true}] |
Cost of Revenue | 6.81M | 6.03M | 3.75M | 2.59M | 5.55M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":88.63,"profit":true},{"date":"2021-12-31","value":55.14,"profit":true},{"date":"2022-12-31","value":38.07,"profit":true},{"date":"2023-12-31","value":81.49,"profit":true}] |
Gross Profit | (4.52M) | (616.00K) | (935.00K) | (820.00K) | (4.89M) | [{"date":"2019-12-31","value":-451700000,"profit":false},{"date":"2020-12-31","value":-61600000,"profit":false},{"date":"2021-12-31","value":-93500000,"profit":false},{"date":"2022-12-31","value":-82000000,"profit":false},{"date":"2023-12-31","value":-489500000,"profit":false}] |
Gross Margin | (197.34%) | (11.37%) | (33.18%) | (46.30%) | (751.92%) | [{"date":"2019-12-31","value":-197.34,"profit":false},{"date":"2020-12-31","value":-11.37,"profit":false},{"date":"2021-12-31","value":-33.18,"profit":false},{"date":"2022-12-31","value":-46.3,"profit":false},{"date":"2023-12-31","value":-751.92,"profit":false}] |
Operating Expenses | 49.69M | 40.35M | 35.03M | 20.35M | 17.54M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":81.2,"profit":true},{"date":"2021-12-31","value":70.5,"profit":true},{"date":"2022-12-31","value":40.96,"profit":true},{"date":"2023-12-31","value":35.3,"profit":true}] |
Operating Income | (54.20M) | (40.96M) | (35.97M) | (25.30M) | (16.89M) | [{"date":"2019-12-31","value":-5420500000,"profit":false},{"date":"2020-12-31","value":-4096300000,"profit":false},{"date":"2021-12-31","value":-3596500000,"profit":false},{"date":"2022-12-31","value":-2530000000,"profit":false},{"date":"2023-12-31","value":-1688900000,"profit":false}] |
Total Non-Operating Income/Expense | - | 1.18M | 1.74M | 84.82M | 13.20M | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":1.39,"profit":true},{"date":"2021-12-31","value":2.05,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":15.57,"profit":true}] |
Pre-Tax Income | (53.24M) | (40.38M) | (35.09M) | 59.14M | (10.29M) | [{"date":"2019-12-31","value":-90.02,"profit":false},{"date":"2020-12-31","value":-68.27,"profit":false},{"date":"2021-12-31","value":-59.34,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-17.39,"profit":false}] |
Income Taxes | 3.00K | 4.00K | 5.00K | 13.00K | 14.85M | [{"date":"2019-12-31","value":0.02,"profit":true},{"date":"2020-12-31","value":0.03,"profit":true},{"date":"2021-12-31","value":0.03,"profit":true},{"date":"2022-12-31","value":0.09,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | - | (40.38M) | (35.10M) | 59.13M | (25.13M) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-68.29,"profit":false},{"date":"2021-12-31","value":-59.36,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-42.51,"profit":false}] |
Income From Continuous Operations | - | (40.38M) | (35.10M) | 59.13M | (10.29M) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-68.29,"profit":false},{"date":"2021-12-31","value":-59.36,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-17.4,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (53.24M) | (40.38M) | (35.10M) | 47.76M | (18.40M) | [{"date":"2019-12-31","value":-111.49,"profit":false},{"date":"2020-12-31","value":-84.55,"profit":false},{"date":"2021-12-31","value":-73.5,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-38.52,"profit":false}] |
EPS (Diluted) | (13.45) | (9.58) | (5.88) | - | 5.99 | [{"date":"2019-12-31","value":-224.47,"profit":false},{"date":"2020-12-31","value":-159.93,"profit":false},{"date":"2021-12-31","value":-98.16,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
TLPH | |
---|---|
Cash Ratio | 4.02 |
Current Ratio | 4.42 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
TLPH | |
---|---|
ROA (LTM) | -47.26% |
ROE (LTM) | -118.40% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
TLPH | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.54 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.46 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
TLPH | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 38.43 |
P/B | 1.20 |
Price/FCF | NM |
EV/R | 12.53 |
EV/Ebitda | 0.11 |
Talphera Inc. (TLPH) share price today is $0.6571
Yes, Indians can buy shares of Talphera Inc. (TLPH) on Vested. To buy Talphera Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TLPH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Talphera Inc. (TLPH) via the Vested app. You can start investing in Talphera Inc. (TLPH) with a minimum investment of $1.
You can invest in shares of Talphera Inc. (TLPH) via Vested in three simple steps:
The 52-week high price of Talphera Inc. (TLPH) is $1.61. The 52-week low price of Talphera Inc. (TLPH) is $0.62.
The price-to-earnings (P/E) ratio of Talphera Inc. (TLPH) is
The price-to-book (P/B) ratio of Talphera Inc. (TLPH) is 1.20
The dividend yield of Talphera Inc. (TLPH) is 0.00%
The market capitalization of Talphera Inc. (TLPH) is $15.29M
The stock symbol (or ticker) of Talphera Inc. is TLPH